<!DOCTYPE html>
<html lang="en">
<head>
  <!-- Google tag (gtag.js) -->
  <script async src="https://www.googletagmanager.com/gtag/js?id=G-LSRR4KW715"></script>
  <script>
    window.dataLayer = window.dataLayer || [];
    function gtag(){dataLayer.push(arguments);}
    gtag('js', new Date());

    gtag('config', 'G-LSRR4KW715');
  </script>


  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>Case 4.1 - Pre-Conception Care</title>

  <!-- Favicon -->
  <link rel="icon" type="image/png" href="../assets/ShepTech logo.png">
  <link rel="apple-touch-icon" href="../assets/ShepTech logo.png">

  <!-- Primary Meta Tags -->
  <meta name="title" content="Case 4.1 - Pre-Conception Care | MD3 SCP Cases">
  <meta name="description" content="Medical case study for MD3 students.">

  <!-- Open Graph / Facebook -->
  <meta property="fb:app_id" content="your_facebook_app_id">
  <meta property="og:type" content="article">
  <meta property="og:title" content="Case 4.1 - Pre-Conception Care">
  <meta property="og:site_name" content="MD3 SCP Cases">
  <meta property="og:description" content="Medical case study for MD3 students.">
  <meta property="og:image" content="https://md3-scp.netlify.app/assets/ShepTech%20logo.png">
  <link rel="stylesheet" href="../css/case.css">

  <!-- Firebase SDK -->
  <script src="https://www.gstatic.com/firebasejs/9.22.0/firebase-app-compat.js"></script>
  <script src="https://www.gstatic.com/firebasejs/9.22.0/firebase-auth-compat.js"></script>
  <script src="https://www.gstatic.com/firebasejs/9.22.0/firebase-firestore-compat.js"></script>
</head>
<body>
  <div class="container">
    <div class="case-header">
      <a href="#" class="back-link" onclick="goBack(event)">← Back to Cases</a>
    </div>

    <h1>Case 4.1 – Pre-Conception Care</h1>
    <p class="meta"><strong>Category:</strong> Endocrine & Reproductive Systems | <strong>Discipline:</strong> Obstetrics & Gynaecology | <strong>Setting:</strong> General Practice</p>

    <h2>Case</h2>
    <p>Harpa Singh aged 38 years presents to your general practice. She is known to you as an insulin-dependant diabetic. She has recently married and is hoping to conceive. She asks how she should prepare for pregnancy and in view of her age what are the risks of a chromosomal abnormality.</p>

    <h2>Questions</h2>

    <div class="question">
      <strong>1. Describe the factors you would discuss that help assess the risks for this pregnancy for Harpa and for her baby.</strong><br>
      <button class="toggle">Show Answer</button>
      <div class="answer">
        <p><strong>Preconception Counselling - Risks of Pregnancy to Patient and Foetus:</strong></p>

        <p><strong>Individual Factors:</strong></p>
        <ul>
          <li><strong>Age</strong> - at 38 years, increased risk of chromosomal abnormalities</li>
          <li><strong>Ethnic background</strong> - certain genetic conditions more common in specific populations</li>
          <li><strong>Family history</strong> - chromosomal or genetic disorders</li>
        </ul>

        <p><strong>Social Factors:</strong></p>
        <ul>
          <li>Partner and family support</li>
          <li>Work situation</li>
          <li>Access to health care</li>
        </ul>

        <p><strong>Health Behaviours:</strong></p>
        <ul>
          <li>Smoking status</li>
          <li>Alcohol use</li>
          <li>Recreational drug use</li>
        </ul>

        <p><strong>Psychological Factors:</strong></p>
        <ul>
          <li>Depression</li>
          <li>Anxiety</li>
          <li>Stress</li>
          <li>History of abuse</li>
        </ul>

        <p><strong>Reproductive History:</strong></p>
        <ul>
          <li>Previous pregnancies and outcomes</li>
        </ul>

        <p><strong>Medical History:</strong></p>
        <ul>
          <li>Any ongoing medical problems (particularly her insulin-dependent diabetes)</li>
          <li>Current medications and their safety in pregnancy</li>
        </ul>

        <p><strong>Vaccinations:</strong></p>
        <ul>
          <li>Particularly rubella and varicella zoster if seronegative</li>
          <li>Diphtheria, tetanus, pertussis</li>
          <li>Measles</li>
        </ul>

        <p><strong>Nutrition:</strong></p>
        <ul>
          <li>Vegetarian diet</li>
          <li>History of malabsorption</li>
        </ul>

        <p><strong>Family History:</strong></p>
        <ul>
          <li>If high risk of chromosomal or genetic disorder, pre-pregnancy genetic testing and counselling may enable couple to consider relative merits of pre-implantation genetic diagnosis versus prenatal diagnosis in pregnancy</li>
        </ul>
      </div>
    </div>

    <div class="question">
      <strong>2. Outline the general advice and the particular advice you would give.</strong><br>
      <button class="toggle">Show Answer</button>
      <div class="answer">
        <h3>General Advice</h3>

        <p><strong>Nutrition:</strong></p>
        <ul>
          <li><strong>Preconception folic acid supplementation</strong></li>
          <li>Diet: meat and green vegetables for iron</li>
          <li>3 serves dairy products for 1000mg calcium</li>
          <li>Measures to avoid listeria (avoid soft cheeses, deli meats, etc.)</li>
          <li>Increased fluid intake and adequate fibre to avoid constipation</li>
          <li><strong>Supplement 150mcg iodine</strong></li>
          <li>Role of multivitamins</li>
        </ul>

        <p><strong>Drugs and Substances:</strong></p>
        <ul>
          <li>Quit program for smoking</li>
          <li>Recommend avoid alcohol and recreational drugs</li>
        </ul>

        <p><strong>Sexual Health:</strong></p>
        <ul>
          <li>STI screen, hepatitis, HIV</li>
        </ul>

        <p><strong>Lifestyle:</strong></p>
        <ul>
          <li>Regular exercise</li>
          <li>Weight control</li>
          <li>Dental hygiene</li>
        </ul>

        <p><strong>Medication Review:</strong></p>
        <ul>
          <li>Review all current medications (e.g., anti-hypertensive, anti-epileptic, anti-depressant)</li>
        </ul>

        <p><strong>Expectations:</strong></p>
        <ul>
          <li>Reassure that conception may take up to one year</li>
          <li>Record dates of period on a calendar</li>
          <li>General outline of antenatal care and first trimester screening</li>
          <li>Early pregnancy symptoms (nausea, breast tenderness, fatigue, urinary frequency)</li>
        </ul>

        <p><strong>Other Advice:</strong></p>
        <ul>
          <li>If she has a cat, avoid contact with its faeces (risk of toxoplasmosis)</li>
        </ul>

        <h3>Specific Advice for Harpa (Diabetes)</h3>

        <p><strong>Risk to Baby:</strong></p>
        <ul>
          <li>Risk of foetal congenital abnormality is high (cardiac defects and neural tube abnormalities)</li>
        </ul>

        <p><strong>Diabetic Control:</strong></p>
        <ul>
          <li><strong>Strict diabetic control</strong> essential for conception and pregnancy</li>
          <li>Monitor HbA1C and keep in normal range</li>
          <li>Insulin needs will increase through pregnancy</li>
          <li><strong>Refer to endocrinologist</strong> for reassessment of diabetes, renal and eye disease</li>
        </ul>

        <p><strong>High-Dose Folic Acid:</strong></p>
        <ul>
          <li><strong>Folic acid 5mg</strong> (instead of usual 0.4mg) for one month pre-conception at least and until 12 weeks pregnant</li>
          <li>5mg indicated if: previous baby or family history of neural tube defect, diabetes mellitus, epilepsy, BMI > 30, or malabsorption</li>
        </ul>
      </div>
    </div>

    <div class="question">
      <strong>3. Outline the examination you would perform and list the investigations you would recommend.</strong><br>
      <button class="toggle">Show Answer</button>
      <div class="answer">
        <h3>Examination</h3>
        <ul>
          <li><strong>Height and weight</strong> for BMI calculation</li>
          <li><strong>Blood pressure</strong></li>
          <li><strong>Auscultation</strong> of heart and lung fields</li>
          <li><strong>Breast examination</strong></li>
          <li><strong>Abdominal palpation</strong></li>
          <li>Check for <strong>lymphadenopathy</strong></li>
          <li>Check for <strong>thyroid swellings</strong></li>
          <li><strong>Pelvic examination</strong> if relevant</li>
        </ul>

        <h3>Investigations</h3>
        <ul>
          <li><strong>Cervical Screening test</strong></li>
          <li><strong>Rubella and varicella serology</strong></li>
          <li><strong>FBC</strong> (Full Blood Count)</li>
          <li><strong>Ferritin</strong> if vegetarian or heavy menses</li>
          <li><strong>Blood group</strong></li>
          <li><strong>Vitamin D levels</strong> if appropriate</li>
          <li><strong>Genetic test</strong> if indicated</li>
          <li><strong>Urine analysis</strong></li>
        </ul>
      </div>
    </div>

    <div class="question">
      <strong>4. Harpa is worried that at age 38 she is at increased risk to have a baby with an abnormality. Describe to her the current screening and diagnostic tests available.</strong><br>
      <button class="toggle">Show Answer</button>
      <div class="answer">
        <p><strong>Background Information:</strong></p>
        <ul>
          <li>50% of babies with a chromosomal abnormality are born to women younger than 35</li>
          <li>All pregnant women should receive counselling and be offered screening for chromosomal abnormalities (chromosomes 21, 18, 13)</li>
          <li><strong>Risk of Down's syndrome: 1 in 300 at age 35 and 1 in 100 at age 40</strong></li>
        </ul>

        <h3>Screening Tests</h3>

        <p><strong>Combined First Trimester Screen (11-13+6 weeks):</strong></p>
        <ul>
          <li>Incorporates maternal age, ultrasound measurement of foetal nuchal translucency, and maternal serum markers (Papp-A - Pregnancy-associated plasma protein A & betaHCG)</li>
          <li>Generates an overall risk figure for trisomy 21</li>
          <li>Sensitivity: 85%, Specificity: 95%, Positive Predictive Value: 7-10%</li>
        </ul>

        <p><strong>Cell-free DNA (cfDNA) NIPT - Non-Invasive Prenatal Test (\&gt;10 weeks):</strong></p>
        <ul>
          <li>DNA from foetus found in maternal blood</li>
          <li>May need repeat in obesity</li>
          <li>Sensitivity: 99%, Specificity: 99%, Positive Predictive Value: 45%</li>
        </ul>

        <p><strong>Quadruple Test (15-20 weeks) - for late booking:</strong></p>
        <ul>
          <li>Maternal age + AFP + betaHCG + UE3 + inhibin A</li>
          <li>Sensitivity: 75%, Specificity: 95%, Positive Predictive Value: 2-3%</li>
        </ul>

        <p><strong>Morphology Ultrasound (18 weeks):</strong></p>
        <ul>
          <li>Detailed anatomical survey</li>
        </ul>

        <table>
          <tr>
            <th>Investigation Value</th>
            <th>Gestation</th>
            <th>Sensitivity</th>
            <th>Specificity</th>
            <th>Positive Predictive</th>
          </tr>
          <tr>
            <td>Combined first trimester<br>Mat age+NT+betaHCG+Papp-A</td>
            <td>11-13+6 weeks</td>
            <td>85%</td>
            <td>95%</td>
            <td>7-10%</td>
          </tr>
          <tr>
            <td>Quadruple Test (late booking)<br>Mat age+AFP+betaHCG+UE3+inhibin</td>
            <td>15-20 weeks</td>
            <td>75%</td>
            <td>95%</td>
            <td>2-3%</td>
          </tr>
          <tr>
            <td>Cell-free DNA screening (NIPT)</td>
            <td>>10 weeks</td>
            <td>99%</td>
            <td>99%</td>
            <td>45%</td>
          </tr>
        </table>

        <h3>Diagnostic Tests</h3>
        <p><strong>All abnormal screening tests require confirmation.</strong></p>

        <p><strong>Amniocentesis (from 15 weeks):</strong></p>
        <ul>
          <li>Foetal cells are cultured from amniotic fluid aspirated from uterus</li>
          <li>Performed under ultrasound guidance</li>
          <li>Before 14 weeks: increased risk of talipes</li>
        </ul>

        <p><strong>Chorionic Villus Sampling (CVS) (after 11 weeks):</strong></p>
        <ul>
          <li>Aspiration under ultrasound of chorionic villi for genetic testing</li>
          <li>Before 11 weeks: risk of transverse limb reduction defects</li>
        </ul>

        <p><strong>Testing Methods:</strong></p>
        <ul>
          <li><strong>Conventional (G-banded) Karyotyping</strong> - uses cultured foetal cells</li>
          <li><strong>Rapid aneuploidy tests - FISH</strong> (fluorescent in situ hybridization) - adjunct to above for rapid assessment</li>
          <li><strong>Chromosomal Microarray analysis</strong> - assess foetal genome if foetal abnormality detected at ultrasound</li>
        </ul>
      </div>
    </div>

    <div class="question">
      <strong>5. What are the current Australian recommendations for the use of alcohol and smoking in pregnancy?</strong><br>
      <button class="toggle">Show Answer</button>
      <div class="answer">
        <h3>Alcohol Recommendations</h3>
        <ul>
          <li>Excessive alcohol can damage foetal development</li>
          <li><strong>The minimum or threshold level at which alcohol begins to pose a significant threat to pregnancy is not known</strong></li>
          <li><strong>Avoidance of alcohol in pregnancy is recommended</strong></li>
        </ul>

        <h3>Smoking Recommendations</h3>
        <p><strong>Risks of Smoking:</strong></p>
        <ul>
          <li>Increases risk of infertility</li>
          <li>Increases risk of miscarriage</li>
          <li>Increases risk of adverse events in pregnancy</li>
          <li>Increases risk of respiratory disease in the baby</li>
          <li>Increases risk of sudden infant death syndrome (SIDS)</li>
        </ul>

        <p><strong>Management:</strong></p>
        <ul>
          <li>Women should be screened for smoking</li>
          <li>Given counselling and behavioural support</li>
          <li>Provided with written information</li>
          <li>Referral to QUIT programs</li>
          <li><strong>Nicotine replacement therapy is NOT recommended in pregnancy</strong></li>
        </ul>
      </div>
    </div>

    <div class="question">
      <strong>6. How might your advice change if Harpa had epilepsy, hypertension, thyroid disease, or depression?</strong><br>
      <button class="toggle">Show Answer</button>
      <div class="answer">
        <p><strong>General Principles for Chronic Medical Conditions:</strong></p>
        <ul>
          <li>Some medications present increased risks for foetal abnormality or growth and need to be changed prior to conception</li>
          <li><strong>Always check in MIMS or with the respective specialist that the current medication is safe in pregnancy</strong></li>
          <li>Referral for pre-natal foeto-maternal review may be indicated</li>
        </ul>

        <h3>Epilepsy</h3>
        <ul>
          <li><strong>High-dose folic acid 5mg</strong> (same as for diabetes)</li>
          <li>Medication review essential - some anti-epileptic drugs (AEDs) are teratogenic (e.g., sodium valproate has highest risk)</li>
          <li>Serum levels of anti-epileptic medications decline with increasing haemodilution of pregnancy</li>
          <li>Serum levels need to be checked throughout pregnancy and dosage adjusted as indicated</li>
          <li>Balance between seizure control and foetal safety</li>
          <li>Referral to neurologist recommended</li>
        </ul>

        <h3>Hypertension</h3>
        <ul>
          <li>Review anti-hypertensive medications - some are contraindicated in pregnancy (e.g., ACE inhibitors, ARBs)</li>
          <li>Switch to pregnancy-safe options (e.g., methyldopa, labetalol, nifedipine)</li>
          <li>Increased risk of pre-eclampsia and other pregnancy complications</li>
          <li>May need closer monitoring during pregnancy</li>
        </ul>

        <h3>Thyroid Disease</h3>
        <ul>
          <li>Optimal thyroid function crucial for pregnancy</li>
          <li>Serum levels of thyroxine decline with increasing haemodilution of pregnancy</li>
          <li>Serum levels need to be checked throughout pregnancy and dosage adjusted as indicated</li>
          <li>Both hypothyroidism and hyperthyroidism can affect fertility and pregnancy outcomes</li>
          <li>Aim for TSH in lower half of normal range before conception</li>
          <li>May need to increase thyroxine dose by 25-30% in pregnancy</li>
        </ul>

        <h3>Depression</h3>
        <ul>
          <li>Review anti-depressant medications for safety in pregnancy</li>
          <li>Balance between maternal mental health and foetal medication exposure</li>
          <li>Most SSRIs considered relatively safe (though some concerns about paroxetine)</li>
          <li>Untreated depression carries its own risks to mother and baby</li>
          <li>May need referral to perinatal psychiatry service</li>
          <li>Increased support and monitoring during pregnancy and postpartum period</li>
        </ul>
      </div>
    </div>

  
</div>

<!-- JavaScript -->  <script src="../js/firebase-config.js"></script>
  <script src="../js/dark-mode.js"></script>
  <script src="../js/auth.js"></script>
  <script src="../js/completion-tracker.js"></script>
  <script src="../js/flag-tracker.js"></script>
  <script src="../js/case-interactions.js"></script>

  <script>
    // Toggle case completion
    function toggleCaseCompletion() {
      if (window.completionTracker) {
        const caseId = window.completionTracker.getCurrentCaseId();
        if (caseId) {
          window.completionTracker.toggleCompletion(caseId);
        }
      }
    }// Toggle case flag
    function toggleCaseFlag() {
      console.log('toggleCaseFlag() function called');
      console.log('window.flagTracker exists:', !!window.flagTracker);

      if (!window.flagTracker) {
        console.error('window.flagTracker is not defined!');
        alert('Flag tracker not initialized. Please refresh the page.');
        return;
      }

      const caseId = window.flagTracker.getCurrentCaseId();
      console.log('Current case ID:', caseId);

      if (!caseId) {
        console.error('Could not get case ID');
        alert('Could not determine case ID');
        return;
      }

      console.log('Calling window.flagTracker.toggleCaseFlag with caseId:', caseId);
      window.flagTracker.toggleCaseFlag(caseId);
    }

    // Update case flag button state on page load
    document.addEventListener('DOMContentLoaded', () => {
      if (window.flagTracker) {
        setTimeout(() => {
          const caseId = window.flagTracker.getCurrentCaseId();
          if (caseId) {
            window.flagTracker.updateCaseFlagButton(caseId);
          }
        }, 100);
      }
    });
    }
  </script>

</body>
</html>
